The Clorox Company (NYSE:CLX) Holdings Decreased by Tobam

Tobam reduced its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 42.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 45,758 shares of the company's stock after selling 33,319 shares during the quarter. Clorox accounts for 2.3% of Tobam's portfolio, making the stock its 4th biggest holding. Tobam's holdings in Clorox were worth $7,432,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. Insight Folios Inc lifted its stake in Clorox by 3.0% during the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company's stock valued at $358,000 after acquiring an additional 63 shares during the period. HCR Wealth Advisors raised its holdings in shares of Clorox by 1.0% during the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company's stock valued at $1,116,000 after purchasing an additional 68 shares during the last quarter. Empower Advisory Group LLC lifted its holdings in shares of Clorox by 4.5% during the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company's stock valued at $297,000 after buying an additional 78 shares during the period. Aviance Capital Partners LLC grew its stake in shares of Clorox by 2.7% during the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company's stock valued at $502,000 after purchasing an additional 80 shares during the period. Finally, Lindbrook Capital LLC increased its holdings in Clorox by 9.9% during the third quarter. Lindbrook Capital LLC now owns 977 shares of the company's stock valued at $159,000 after buying an additional 88 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have issued reports on CLX. DA Davidson cut their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Wells Fargo & Company raised their target price on shares of Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 4th. Evercore ISI upped their price target on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Finally, Barclays lifted their target price on shares of Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research note on Wednesday, February 5th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat.com, Clorox presently has an average rating of "Hold" and a consensus price target of $158.21.

Clorox Trading Up 0.6 %

Shares of Clorox stock traded up $0.87 during trading on Tuesday, hitting $148.01. The stock had a trading volume of 472,473 shares, compared to its average volume of 1,334,355. The firm's fifty day simple moving average is $160.68 and its 200-day simple moving average is $159.16. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The stock has a market cap of $18.32 billion, a PE ratio of 40.39, a PEG ratio of 2.52 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the firm posted $2.16 earnings per share. As a group, sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.30%. The ex-dividend date is Wednesday, January 29th. Clorox's payout ratio is 133.33%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.